Cryptocurrency Analysis and News Portal
During the first three months of 2021, Johnson & Johnson reported revenue of $22.32 billion versus $21.98 billion expected by analysts. Healthcare company Johnson & Johnson (NYSE: JNJ) stock has jumped over 2.5% on Tuesday, April 20, 2020, as of 11:00 a.m EDT to trade around
Read More
The vaccine developed by Johnson & Johnson has varying efficacies as shown by FDA documents. In the United States, efficiency is at 72%, 66% in Latin America, and about 64% in South Africa.The United States Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to the single-shot
Read More
Johnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials.Johnson & Johnson (NYSE: JNJ) is set to begin late-stage COVID-19 vaccine trials in September. It will be ahead of schedule. Meanwhile, Johnson & Johnson also indicated that its phase one trial should
Read More